Related Experiment Video
Updated: Jul 16, 2025

A TNBS-Induced Rodent Model to Study the Pathogenic Role of Mechanical Stress in Crohn's Disease
Published on: March 1, 2022
Unmet Challenges in Patients with Crohn's Disease
Katharina M Scheurlen1, Mary A Parks1, Anne Macleod1
1Price Institute of Surgical Research, Hiram C. Polk Jr. MD Department of Surgery, University of Louisville, Louisville, KY 40202, USA.
Standardized management is lacking for Crohn's disease, impacting diagnosis, prognosis, and treatment. Further research is needed for reliable biomarkers and novel therapies to improve patient outcomes.
Area of Science:
- Gastroenterology and Hepatology
- Inflammatory Bowel Disease Research
- Clinical Management Strategies
Background:
- Crohn's disease presents diverse clinical manifestations, necessitating improved long-term management for remission and quality of life.
- Current approaches lack standardization in diagnosis, prognosis prediction, and treatment, leading to significant unmet needs.
- Complications and treatment failures highlight the urgent need for standardized therapeutic algorithms.
Purpose of the Study:
- To review current research on standardized processes for managing Crohn's disease.
- To identify unmet needs in the clinical evaluation and treatment of Crohn's disease patients.
- To discuss challenges in diagnosing, predicting prognosis, and treating Crohn's disease.
Main Methods:
- A narrative review methodology was employed.
- Literature search conducted across PubMed, Embase, and Science Direct databases.
- Data extraction focused on unmet challenges in Crohn's disease management.
Main Results:
- No consensus exists on standardized diagnostic, treatment, or surveillance algorithms for Crohn's disease.
- Challenges persist in assessing complications like stricturing disease, cancer risk, and cutaneous manifestations.
- High rates of complications and treatment failure underscore the need for standardized approaches.
Conclusions:
- Standardized clinical approaches, reliable biomarkers for diagnosis and monitoring, and new therapeutic agents are crucial.
- Improved management strategies are necessary to reduce complications and enhance therapy for Crohn's disease patients.
- Further research is essential to establish standardized algorithms and novel treatments for Crohn's disease.
More Related Videos
07:38Multimodal Quantitative Phase Imaging with Digital Holographic Microscopy Accurately Assesses Intestinal Inflammation and Epithelial Wound Healing
Published on: September 13, 2016
07:06Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
Published on: December 8, 2014
Related Concept Videos
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Chronic Bowel Disorders: Introduction
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
Inflammatory Bowel Disease V: Surgical Management
Here are some common surgical interventions for IBD:
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids